| | 1585988-92-6 Basic information More.. |
| Product Name: | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-
phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]
dioxaphosphocin | | Synonyms: | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-
phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]
dioxaphosphocin;(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin,99%e.e.;(11AS)-10,11,12,13-TETRAHYDRO-5-HYDROXY-3,7-DI-9-PHENANTHRENYL-5-OXIDE-DIINDENO[7,1-DE:1',7'-FG][1,3,2]DIOXAPHOSPHOCIN,MIN.98%;(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-, 5-oxide, (11aS)- | | CAS: | 1585988-92-6 | | MF: | C45H31O4P | | MW: | 666.7 | | EINECS: | | | Mol File: | 1585988-92-6.mol |  |
|
|
1585988-92-6
Recommend Suppliers |
| Company Name: |
Shanghai Chiral bio-compound co., Ltd.
Recommend
Complaint |
 |
| Tel: |
021-5068 3667/17749785980/1029026415; |
| FAX: |
021-50683667 |
| Email: |
1029026415@qq.com |
| Products Intro: |
Product Name:(11aS)-5-oxide-10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin CAS:1585988-92-6 Purity:97% Package:100mg,1g,100g,1kg
More... |
| CB Index: |
58 |
| WebSite: |
http://www.chiralmol.com/ |
| Related Information: |
Sales Network
Catalog(4501)
User Evaluation
|
| Company Name: |
Greenherbs Science and Technology Development Co., Ltd.
Recommend
Complaint |
 |
| Tel: |
010-61136123 |
| FAX: |
+86 (10) 8857-9127 |
| Email: |
pub02@greenherbs.com.cn |
| Products Intro: |
Product Name:(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin CAS:1585988-92-6 Purity:98%,99%e.e. Package:0.025g,0.1g,1g Remarks:135844
More... |
| CB Index: |
58 |
| WebSite: |
www.greenherbs.com.cn |
| Related Information: |
Sales Network
Catalog(4045)
User Evaluation
|
|